CStone Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, CStone Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $14.33. The average 1-year stock price forecast is 209.50% higher than the current stock price, while the lowest is $9.65 (+108.42%) and the highest is $19.99 (+331.75%).

Price Target: $14.33 (+209.50%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$9.65	$14.33	$13.85	$19.99
Change	+108.42%	+209.50%	+199.14%	+331.75%

* Price targets were last updated on Mar 31, 2026.

Analyst Ratings

The average analyst rating for CStone Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Oct '25	Feb '26	Mar '26	Apr '26	Jun '26
Strong Buy	2	3	3	3	3	3
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst Goldman Sachs No rating	Goldman Sachs	Buy Maintains $8.26 → $9.44	Buy	Maintains	$8.26 → $9.44	+103.89%	Mar 31, 2026
Unknown Analyst Guoyuan Securities (HK) No rating	Guoyuan Securities (HK)	Buy Maintains $10.30	Buy	Maintains	$10.30	+122.46%	Mar 3, 2026

Financial Forecast

Revenue This Year

479.31M

from 269.58M

77.80%

from 269.58M

Revenue Next Year

1.71B

from 479.31M

257.45%

from 479.31M

EPS This Year

0.20

from -

EPS Next Year

-0.16

from 0.20

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	243.72M	481.36M	463.84M	407.21M	269.58M	479.31M
Revenue Growth	-76.54%	97.51%	-3.64%	-12.21%	-33.80%	77.80%
Gross Profit	136.89M	278.38M	304.30M	240.15M	51.25M	296.46M
Gross Margin	56.17%	57.83%	65.60%	58.98%	19.01%	61.85%
Operating Income	-1.83B	-912.15M	-579.16M	-95.36M	-415.83M	-283.65M
Net Income	-1.92B	-902.68M	-367.23M	-91.21M	-437.00M	-215.23M
EPS	-	-	-	-	-	0.20
Forward PE	-	-	-	-	14.08	20.19
Free Cash Flow	-1.05B	-398.41M	-495.11M	-233.08M	-251.06M	2.00M
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue	2026	2027	2028
High	609.0M
Avg	479.3M
Low	401.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	125.9%
Avg	77.8%
Low	48.8%

EPS Forecast

EPS	2026	2027	2028
High	0.37
Avg	0.20
Low	0.03

EPS Growth

EPS Growth	2027	2028
High	-82.3%
Avg	-
Low	-